9 Meters Biopharma Inc reports results for the quarter ended in March - Earnings Summary

9 Meters Biopharma

16/05/2023 01:26

* 9 Meters Biopharma Inc  NMTR.OQ  reported a quarterly
adjusted
loss of $1.02​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 78 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * 9 Meters Biopharma Inc's reported EPS for the quarter was
a loss
of $1.02​.
    * The mean earnings estimate of analysts had fallen by
about 95.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * 9 Meters Biopharma Inc shares had fallen by 45.5% this
quarter and lost 39.8% so far this year.
    * The company reported a quarterly loss of $13.9 million.
    * Wall Street's median 12-month price target for 9 Meters
Biopharma Inc is $20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 12:25 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.78          -1.02          Missed
 Dec. 31 2022      -0.76          -0.92          Missed
 Sep. 30 2022      -0.82          -0.72          Beat
 Jun. 30 2022      -0.83          -0.80          Beat